Liang Xu

机构：Tianjin University of Traditional Chinese Medicine, University of Science and Technology of China, Tianjin People's Hospital, Anhui Provincial Hospital, Zhejiang Provincial People's Hospital, Second Hospital of Tianjin Medical University, Tianjin Hospital, Institute of Pharmacology, Hangzhou Medical College, Tianjin Medical University · ORCID：0000-0002-9039-6621

发表论文 122 篇 · 总被引 1926 次 · h-index 22

代表论文

Inhibition of the Glycolysis Prevents the Cerebral Infarction Progression Through Decreasing the Lactylation Levels of LCP1 (2022 · Molecular Biotechnology · 被引 81)
The furosemide stress test predicts successful discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury (2024 · Journal of Critical Care · 被引 13)
GRK2 activates TRAF2–NF-κB signalling to promote hyperproliferation of fibroblast-like synoviocytes in rheumatoid arthritis (2025 · Acta Pharmaceutica Sinica B · 被引 8)
Identification of Autophagy-Related Targets of Berberine against Non-Small Cell Lung Cancer and Their Correlation with Immune Cell Infiltration By Combining Network Pharmacology, Molecular Docking, and Experimental Verification (2023 · Critical Reviews in Immunology · 被引 6)
Development and validation of a nomogram for assessing hepatocellular carcinoma risk after SVR in hepatitis C patients with advanced fibrosis and cirrhosis (2024 · Infectious Agents and Cancer · 被引 5)
Tacrolimus Maintains the Balance of Neutrophil Extracellular Traps by Inducing DNA Methylation of Neutrophils to Reduce Immune Rejection (2023 · Life · 被引 4)